This article was originally published on May 12.

Pfizer and the Wisconsin Alumni Research Foundation said last week that they have inked a licensing agreement that gives Pfizer the right to work with human embryonic stem cells for drug research and discovery.

With the deal, WARF has now inked 35 licensing deals with 27 corporate partners for its portfolio of patents related to isolating and differentiating hESCs in the late 1990s, Janet Kelly, WARF's director communications, wrote in an e-mail to BTW.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.